Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Monoamine Oxidase B inhibitor 1 is a potent, reversible, orally active and selective monoamine oxidase B (MAO-B) inhibitor (IC50 = 0.02 nM) that can across the blood-brain barrier (BBB). Monoamine Oxidase B inhibitor 1 shows antioxidant and anti-neuroinflammatory activities that can be used in the study of Parkinson’s disease[1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 10-14 weeks | $ 1,520.00 | |
50 mg | 10-14 weeks | $ 1,980.00 | |
100 mg | 10-14 weeks | $ 2,500.00 |
Description | Monoamine Oxidase B inhibitor 1 is a potent, reversible, orally active and selective monoamine oxidase B (MAO-B) inhibitor (IC50 = 0.02 nM) that can across the blood-brain barrier (BBB). Monoamine Oxidase B inhibitor 1 shows antioxidant and anti-neuroinflammatory activities that can be used in the study of Parkinson’s disease[1]. |
In vitro | In cellular assays, the Monoamine Oxidase B inhibitor 1 (compound 14a; 0.5-10.0 μM) was shown to markedly reduce the levels of NO and TNF-α in LPS-induced BV-2 cells [1]. |
In vivo | In both acute and subacute MPTP-induced Parkinson’s disease mouse models, Monoamine Oxidase B Inhibitor 1 (compound 14a; 6-37.4 mg/kg; orally administered) significantly ameliorated most behavioral disorders, restored dopamine levels and reduced MDA levels in the striatum of mice [1]. |
Molecular Weight | 298.31 |
Formula | C18H15FO3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Monoamine Oxidase B inhibitor 1 inhibitor inhibit